title: Beta-like hippocampal network activity is differentially affected by amyloid beta peptides.
abstract: Alzheimer disease (AD) patients show alterations in both neuronal network oscillations and the cognitive processes associated to them. Related to this clinical observation, it has been found that amyloid beta protein (Abeta) differentially affects some hippocampal network activities, reducing theta and gamma oscillations, without affecting sharp waves and ripples. Beta-like oscillations is another cognitive-related network activity that can be evoked in hippocampal slices by several experimental manipulations, including bath application of kainate and increasing extracellular potassium. Here, we tested whether or not different Abeta peptides differentially affect beta-like oscillatory patterns. We specifically tested the effects of fresh dissolved Abeta(25-35) and oligomerized Abeta(1-42) and found that kainate-induced oscillatory network activity was affected, in a slightly concentration dependent-manner, by both fresh dissolved (mostly monomeric) Abeta(25-35) and oligomeric Abeta(1-42). In contrast, potassium-induced oscillatory activity, which is reduced by oligomeric Abeta(1-42), is not affected by monomeric Abeta(25-35) at any of the concentrations tested. Our results support the idea that different amyloid peptides might alter specific cellular mechanisms related to the generation of specific neuronal network activities, instead of a generalized inhibitory effect of Abeta peptides on neuronal network function.
authors.affiliation: Departamento de Farmacobiología, Cinvestav-Sede Sur, México, D.F., México.
authors.forename: Alvaro
authors.initials: A
authors.lastname: Adaya-Villanueva
authors.forename: Benito
authors.initials: B
authors.lastname: Ordaz
authors.forename: Hugo
authors.initials: H
authors.lastname: Balleza-Tapia
authors.forename: Abraham
authors.initials: A
authors.lastname: Márquez-Ramos
authors.forename: Fernando
authors.initials: F
authors.lastname: Peña-Ortega
mesh_terms: D000544:Alzheimer Disease / Q000503:physiopathology; D016229:Amyloid beta-Peptides / Q000378:metabolism*; D000818:Animals; D055664:Electrochemical Techniques; D018690:Excitatory Amino Acid Agonists / Q000494:pharmacology; D006624:Hippocampus / Q000187:drug effects / Q000503:physiopathology*; D006801:Humans; D066298:In Vitro Techniques; D007608:Kainic Acid / Q000494:pharmacology; D009415:Nerve Net / Q000187:drug effects / Q000503:physiopathology*; D009994:Osmolar Concentration; D010446:Peptide Fragments / Q000378:metabolism; D010477:Perfusion; D011188:Potassium / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D009435:Synaptic Transmission / Q000187:drug effects*
chemical_list: D016229:Amyloid beta-Peptides; D018690:Excitatory Amino Acid Agonists; D010446:Peptide Fragments; C074636:amyloid beta-protein (25-35); C544092:beta-amyloid peptide 1-42 (E22delta) click peptide; D011188:Potassium; D007608:Kainic Acid